A
Aker BioMarine
A biotech and Antarctic krill harvesting company dedicated to improving human and planetary health
About Aker BioMarine
Aker BioMarine is a biotechnology company specializing in the development of krill-based bioactive ingredients. These ingredients are used in various markets, including nutraceuticals (health supplements), aquaculture (fish farming), and animal feed. The company operates a fully traceable value chain, starting from sustainable krill harvesting operations in Antarctica, through a logistics hub in Montevideo, and ending at a state-of-the-art factory in Houston. Aker BioMarine serves clients who are looking for high-quality, sustainable ingredients to enhance the health and performance of humans, fish, and pets. The business model focuses on sustainability and innovation, leveraging its expertise in krill harvesting to create value-added products. Revenue is generated through the sale of these specialized ingredients to manufacturers in the health, aquaculture, and pet food industries.
Source: Dealroom company dataAt a glance
- Founded
- 2002
- Headquarters
- Norway
- Sector
- Biotech & Life Sciences
- Power Law
- Thoroughbred$100M+ revenue
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Innovation Norway
Series B and later1 investor entered at this stage
Aker ASA
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Patents
34 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Aker BioMarine on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Aker BioMarine on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
